LAVAL, QC – Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), (“Bausch Health” or the “Company”) announced the first public drug plan listings for PrUCERIS® (budesonide) aerosol… Read More
Dr. Devon Greyson, an assistant professor at the UBC Faculty of Medicine’s School of Population and Public Health, has been appointed an Applied Public Health Chair by the Canadian Institutes… Read More
Thrive Health’s first appearance on Canada’s Top Small & Medium Employers list spotlights its exemplary workplace culture and prioritization of wellness for employees VANCOUVER, BC – Thrive Health, a leader… Read More
Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the… Read More
Lexaria receives new patents in the fields of epilepsy and anti-viral agents KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms… Read More
